Ex-AstraZeneca exec appointed to Takeda advisory board
This article was originally published in Scrip
Executive Summary
Bruno Angelici has been appointed to Takeda's global advisory board, effective 1 October. The former AstraZeneca Japan president and AstraZeneca executive vice-president, international, replaces Dr Frank Morich, who took up a position the same day as executive vice-president of Takeda's international (Americas and Europe) operations. The board was formed in mid-2009 to help guide the Japanese firm's international business and project development strategy.